The effect of dapagliflozin on accelerometer-based measures of physical activity in heart failure: an exploratory analysis of the DETERMINE trials
30 August 2024 (16:15 - 16:27)
Organised by: 
Slides
About the speaker
University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
4 More presentations in this session
Doctor D. Birnie (Ottawa, CA)
Professor C. Sohns (Bad Oeynhausen, DE)
Rapid detection of incident heart failure by artificial intelligence: lessons from the NIL-CHF trial
Professor S. Stewart (Fremantle, AU)
Access the full session
The Event
ESC Congress 2024
30 August 2024
16:15 CET
